Source: Mesoblast Limited
Posted: September 20, 2006
Summary:
Australian adult stem cell company Mesoblast Limited announced positive initial results of clinical adult stem cell trials for the treatment of heart disease being conducted in conjunction with its United States-based sister company Angioblast Systems Inc.
Commentary: Maybe the results of this trial will lead to more trials using adult stem cells to treat heart disease, enabling stem cells to eventually become a standard treatment for heart disease.
No comments:
Post a Comment